[go: up one dir, main page]

WO2008147468A3 - Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use - Google Patents

Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use Download PDF

Info

Publication number
WO2008147468A3
WO2008147468A3 PCT/US2007/087922 US2007087922W WO2008147468A3 WO 2008147468 A3 WO2008147468 A3 WO 2008147468A3 US 2007087922 W US2007087922 W US 2007087922W WO 2008147468 A3 WO2008147468 A3 WO 2008147468A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
virus
therapeutic agent
interacting
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/087922
Other languages
French (fr)
Other versions
WO2008147468A2 (en
Inventor
Jerald W Darlington
John Hughes
Panayiotis P Constantinides
Mingming Fang
Onge Jason Harold St
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amcol International Corp
Original Assignee
Amcol International Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amcol International Corp filed Critical Amcol International Corp
Priority to CA002673313A priority Critical patent/CA2673313A1/en
Publication of WO2008147468A2 publication Critical patent/WO2008147468A2/en
Publication of WO2008147468A3 publication Critical patent/WO2008147468A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Layered phyllosilicates are useful for adsorbing and/or binding to and, thereby, inactivating viruses. Accordingly, provided herein are methods of inactivating a virus and methods of treating a viral infection. Methods of delivering a therapeutic agent to a mammalian subject and methods of inactivating a virus in the gastrointestinal tract of an animal are also provided.
PCT/US2007/087922 2006-12-18 2007-12-18 Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use Ceased WO2008147468A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002673313A CA2673313A1 (en) 2006-12-18 2007-12-18 Virus-interacting layered phyllosilicates and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US96653706P 2006-12-18 2006-12-18
US96653806P 2006-12-18 2006-12-18
US60/966,537 2006-12-18
US60/966,538 2006-12-18

Publications (2)

Publication Number Publication Date
WO2008147468A2 WO2008147468A2 (en) 2008-12-04
WO2008147468A3 true WO2008147468A3 (en) 2009-02-12

Family

ID=39951566

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/087922 Ceased WO2008147468A2 (en) 2006-12-18 2007-12-18 Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use

Country Status (2)

Country Link
CA (1) CA2673313A1 (en)
WO (1) WO2008147468A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272769A1 (en) * 2005-08-03 2010-10-28 Amcol International Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
EP2211868B1 (en) 2007-10-15 2017-08-02 7 Oaks Pharmaceutical Corporation Silicate containing compositions for the treatment of melanoma
SG181421A1 (en) * 2009-12-22 2012-07-30 Marinomed Biotechnologie Gmbh Synergistic antiviral composition and use thereof
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
EP4189051B1 (en) * 2020-07-27 2024-02-28 Unilever IP Holdings B.V. Use of an enzyme and surfactant for inhibiting microorganisms

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
WO2006110385A1 (en) * 2005-04-07 2006-10-19 The Procter & Gamble Company Composition comprising zinc-containing layered material with a high relative zinc lability
WO2007019250A1 (en) * 2005-08-03 2007-02-15 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
WO2006110385A1 (en) * 2005-04-07 2006-10-19 The Procter & Gamble Company Composition comprising zinc-containing layered material with a high relative zinc lability
WO2007019250A1 (en) * 2005-08-03 2007-02-15 Amcol International Corporation Virus-interacting layered phyllosilicates and methods of inactivating viruses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PIAZZOLLA P ET AL: "INFECTIVITY STUDIES ON CUCUMBER MOSAIC VIRUS TREATED WITH A CLAY MATERIAL", JOURNAL OF PHYTOPATHOLOGY (BERLIN), vol. 127, no. 4, 1989, pages 291 - 295, XP002504642, ISSN: 0931-1785 *

Also Published As

Publication number Publication date
CA2673313A1 (en) 2008-12-04
WO2008147468A2 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
WO2009110940A3 (en) Virus-, bacteria-, and fungi-interacting layered phyllosilicates and methods of use
WO2009105513A3 (en) Novel compounds and methods for therapy
WO2008127364A3 (en) Antiviral compounds and use thereof
WO2008113011A3 (en) Virus like particle purification
IL199152A (en) 2-(piperidin-4-yl)-4-phenoxy or phenylamino-pyrimidine derivatives, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for treatment of viral infections
WO2008133663A3 (en) Codon modified immunogenic compositions and methods of use
WO2008115281A3 (en) Compounds for treating viral infections
EP3078377A3 (en) Nitazoxanide and tizoxanide as anti-viral agents
IL187321A0 (en) Host cell specific binding molecules capable of neutralizing viruses and uses thereof
CL2007003765A1 (en) COMPOUNDS DERIVED FROM 2-OXO-4-HIDROXI-BENZOTIAZOL; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS COPD, BRONCHITIS, ASTHMA AND BRONCHIECTASIES.
IL194254A (en) Compositions based on s-adenosyl methionine or nadh , process for their preparation and use thereof in the manufacture of medicaments for the treatment of depression
WO2008120998A3 (en) Acoustically sensitive drug delivery particles
WO2010047830A3 (en) Agents for hcv treatment
CL2007003754A1 (en) COMPOUNDS DERIVED FROM ARIL (HETEROARIL) ALQUIL-AMINA; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE IN THE TREATMENT OF DISEASES SUCH AS BRONCHITIS, PULMONARY DISEASE AND COPD.
WO2008147468A3 (en) Compositions comprising virus-interacting layered phyllosilicates and a therapeutic agent, and methods of use
WO2006074303A3 (en) Delivery vehicles, bioactive substances and viral vaccines
WO2012061248A3 (en) Novel specific hcv ns3 protease inhibitors
WO2009052090A8 (en) Silicate containing compositions and methods of treatment
WO2008027551A3 (en) Dendrimer compositions
IL198598A0 (en) Anti-tsg101 antibodies and their uses for treatment of viral infections
SG10201501376XA (en) Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
IL178094A0 (en) Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
IL207423A (en) Amide compounds, pharmaceutical compositions comprising them and their use in promoting enterokinesis or improving digestive tract function
WO2009001144A3 (en) Pharmaceutical aerosol compositions comprising fluticasone
WO2011078695A3 (en) Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2673313

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07875031

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07875031

Country of ref document: EP

Kind code of ref document: A2